T1	Outcomes 536 543	effects
T2	Outcomes 547 658	mucositis, but no significant effect on engraftment, acute graft-versus-host disease (GVHD), or early survival.
T3	Outcomes 702 779	mucosa, other pleotrophic effects, including more rapid immune reconstitution
T4	Outcomes 904 926	additional differences
T5	Outcomes 1006 1076	CMV or invasive fungal infections, chronic GVHD, or long-term survival
T6	Outcomes 1185 1197	mucotoxicity
